benzylpenicillin potassium salt
p-toluidine
A
3,3-dimethyl-D-cysteine
B
(Z)-N-(p-methylphenyl)-3-(p-methylanilino)-2-(2-phenylacetamido)acrylamide
Conditions | Yield |
---|---|
With acetic acid In water; toluene for 5h; Ambient temperature; Heating; | A 71% B 95% |
2-amino-benzenethiol
(5R,3S)-benzyl-D-penilloic acid
A
3,3-dimethyl-D-cysteine
Conditions | Yield |
---|---|
With acetic acid In water 1.) reflux, 2 h, 2.) room temperature, 1 h; | A 86% B 93% |
naphthalene-1,8-diamine
(5R,3S)-benzyl-D-penilloic acid
A
3,3-dimethyl-D-cysteine
Conditions | Yield |
---|---|
With acetic acid In water for 2h; Heating; | A 93% B 87% |
(5R,3S)-benzyl-D-penilloic acid
A
3,3-dimethyl-D-cysteine
Conditions | Yield |
---|---|
With acetic acid; naphthalene-1,8-diamine In water for 2h; Heating; | A 93% B 87% |
benzylpenicilloic acid α-phenylethylamide
A
benzoimidazole
B
3,3-dimethyl-D-cysteine
C
phenaceturic acid α-phenethylamide
Conditions | Yield |
---|---|
With 1,2-diamino-benzene In water; acetic acid for 1.5h; Heating; | A 59% B 87% C 91% |
benzylpenicilloic acid α-phenylethylamide
1,2-diamino-benzene
A
benzoimidazole
B
3,3-dimethyl-D-cysteine
C
phenaceturic acid α-phenethylamide
Conditions | Yield |
---|---|
In water; acetic acid for 1.5h; Heating; | A 59% B 87% C 91% |
benzylpenicilloic acid α-phenylethylamide
A
3,3-dimethyl-D-cysteine
B
N-phenethyl-α-phenylacetamido-2-benzothiazolidineacetamide
Conditions | Yield |
---|---|
With 2-amino-benzenethiol In water; acetic acid for 2h; Heating; | A 83% B 89% |
benzylpenicilloic acid α-phenylethylamide
2-amino-benzenethiol
A
3,3-dimethyl-D-cysteine
B
N-phenethyl-α-phenylacetamido-2-benzothiazolidineacetamide
Conditions | Yield |
---|---|
In water; acetic acid for 2h; Heating; | A 83% B 89% |
benzylpenicilloic acid α-anilide
A
benzoimidazole
B
3,3-dimethyl-D-cysteine
C
N-phenyl-N2-(phenylacetyl)glycinamide
Conditions | Yield |
---|---|
With 1,2-diamino-benzene In water; acetic acid for 1.5h; Heating; | A 58% B 86% C 81% |
2-amino-benzenethiol
<2R-<2α(R*),4β>>-5,5-dimethyl-2-<2-oxo-1-<(phenylacetyl)amino>-2-<(phenylmethyl)amino>ethyl>-4-thiazolidinecarboxylic acid
A
3,3-dimethyl-D-cysteine
B
N-Benzyl-2-(2,3-dihydro-benzothiazol-2-yl)-2-phenylacetylamino-acetamide
Conditions | Yield |
---|---|
In water; acetic acid for 2h; Heating; | A 81% B 86% |
<2R-<2α(R*),4β>>-5,5-dimethyl-2-<2-oxo-1-<(phenylacetyl)amino>-2-<(phenylmethyl)amino>ethyl>-4-thiazolidinecarboxylic acid
A
3,3-dimethyl-D-cysteine
B
N-Benzyl-2-(2,3-dihydro-benzothiazol-2-yl)-2-phenylacetylamino-acetamide
Conditions | Yield |
---|---|
With 2-amino-benzenethiol In water; acetic acid for 2h; Heating; | A 81% B 86% |
<2R-<2α(R*),4β>>-5,5-dimethyl-2-<2-oxo-1-<(phenylacetyl)amino>-2-<(phenylmethyl)amino>ethyl>-4-thiazolidinecarboxylic acid
A
benzoimidazole
B
3,3-dimethyl-D-cysteine
C
N-benzyl-2-(2-phenylacetamido)acetamide
Conditions | Yield |
---|---|
With 1,2-diamino-benzene In water; acetic acid for 1.5h; Heating; | A 57% B 80% C 85% |
benzylpenicilloic acid α-phenylethylamide
naphthalene-1,8-diamine
A
1-H-perimidine
B
3,3-dimethyl-D-cysteine
C
phenaceturic acid α-phenethylamide
Conditions | Yield |
---|---|
In water; acetic acid for 2h; Heating; | A 85% B 69% C 74% |
3,3-dimethyl-D-cysteine
Conditions | Yield |
---|---|
Stage #1: (S)-2-tert-butoxyamide-3-methyl-3-thioacetoxybutyric acid With hydrogenchloride In 1,4-dioxane; water at 0℃; Reflux; Stage #2: With pyridine In ethanol | 81% |
<2R-<2α(R*),4β>>-2-<2-(ethylamino)-2-oxo-1-<(phenylacetyl)amino>ethyl>-5,5-dimethyl-4-thiazolidinecarboxylic acid
A
benzoimidazole
B
3,3-dimethyl-D-cysteine
C
N-phenylacetyl-glycine ethylamide
Conditions | Yield |
---|---|
With 1,2-diamino-benzene In water; acetic acid for 1.5h; Heating; | A 55% B 71% C 79% |
<2R-<2α(R*),4β>>-2-<2-(ethylamino)-2-oxo-1-<(phenylacetyl)amino>ethyl>-5,5-dimethyl-4-thiazolidinecarboxylic acid
A
3,3-dimethyl-D-cysteine
B
2-(2,3-Dihydro-benzothiazol-2-yl)-N-ethyl-2-phenylacetylamino-acetamide
Conditions | Yield |
---|---|
With 2-amino-benzenethiol In water; acetic acid for 2h; Heating; | A 74% B 79% |
<2R-<2α(R*),4β>>-2-<2-(ethylamino)-2-oxo-1-<(phenylacetyl)amino>ethyl>-5,5-dimethyl-4-thiazolidinecarboxylic acid
2-amino-benzenethiol
A
3,3-dimethyl-D-cysteine
B
2-(2,3-Dihydro-benzothiazol-2-yl)-N-ethyl-2-phenylacetylamino-acetamide
Conditions | Yield |
---|---|
In water; acetic acid for 2h; Heating; | A 74% B 79% |
Conditions | Yield |
---|---|
With acetic acid In water; toluene for 4h; Heating; | A 79% B 9% C 7% |
N,N'-diphenylethylenediamine
A
3,3-dimethyl-D-cysteine
B
N-formyl-N,N'-diphenylethylenediamine
C
phenaceturic acid α-phenethylamide
Conditions | Yield |
---|---|
In acetic acid Heating; | A 51% B 63% C 76% |
In acetic acid for 5h; Mechanism; Heating; var. penicilloic acid α-amides; | A 51% B 63% C 76% |
A
3,3-dimethyl-D-cysteine
B
phenaceturic acid α-phenethylamide
Conditions | Yield |
---|---|
With N,N'-diphenylethylenediamine In acetic acid for 5h; Heating; | A 51% B 76% |
A
3,3-dimethyl-D-cysteine
B
N-phenyl-N2-(phenylacetyl)glycinamide
Conditions | Yield |
---|---|
With N,N'-diphenylethylenediamine In acetic acid Heating; | A 49% B 75% |
Conditions | Yield |
---|---|
With acetic acid In methanol; water | 73.2% |
A
3,3-dimethyl-D-cysteine
B
N-benzyl-2-(2-phenylacetamido)acetamide
Conditions | Yield |
---|---|
With N,N'-diphenylethylenediamine In acetic acid Heating; | A 47% B 72% |
4-methoxy-aniline
benzylpenicilloic acid α-phenylethylamide
A
3,3-dimethyl-D-cysteine
Conditions | Yield |
---|---|
In water; acetic acid; toluene Heating; | A 71% B n/a |
benzylpenicilloic acid α-anilide
2-amino-benzenethiol
A
3,3-dimethyl-D-cysteine
B
2-(2,3-Dihydro-benzothiazol-2-yl)-N-phenyl-2-phenylacetylamino-acetamide
Conditions | Yield |
---|---|
In water; acetic acid for 2h; Heating; | A 71% B 68% |
benzylpenicilloic acid α-anilide
A
3,3-dimethyl-D-cysteine
B
2-(2,3-Dihydro-benzothiazol-2-yl)-N-phenyl-2-phenylacetylamino-acetamide
Conditions | Yield |
---|---|
With 2-amino-benzenethiol In water; acetic acid for 2h; Heating; | A 71% B 68% |
A
3,3-dimethyl-D-cysteine
B
N-phenylacetyl-glycine ethylamide
Conditions | Yield |
---|---|
With N,N'-diphenylethylenediamine In acetic acid Heating; | A 42% B 71% |
A
3,3-dimethyl-D-cysteine
Conditions | Yield |
---|---|
With N,N'-diphenylethylenediamine In acetic acid Heating; | A 47% B 69% |
p-toluidine
benzylpenicilloic acid α-phenylethylamide
A
3,3-dimethyl-D-cysteine
Conditions | Yield |
---|---|
In water; acetic acid; toluene Heating; | A 68% B n/a |
Conditions | Yield |
---|---|
With magnesium sulfate In dichloromethane for 168h; Ambient temperature; | 100% |
3,3-dimethyl-D-cysteine
di-tert-butyl dicarbonate
2-Bromoethyl methyl ether
(2S)-2-((tert-butoxycarbonyl)amino)-3-((2-methoxyethyl)thio)-3-methylbutanoic acid
Conditions | Yield |
---|---|
Stage #1: 3,3-dimethyl-D-cysteine; di-tert-butyl dicarbonate; 2-Bromoethyl methyl ether With sodium hydroxide; ethanol at 0 - 20℃; for 15h; Stage #2: di-tert-butyl dicarbonate With sodium hydroxide; water at 20℃; for 15h; | 100% |
Conditions | Yield |
---|---|
With sodium hydride In methanol at 20℃; Inert atmosphere; | 99% |
With sodium hydride In methanol at 20℃; Inert atmosphere; | 99% |
methanol
3,3-dimethyl-D-cysteine
D-penicillamine methyl ester hydrochloride
Conditions | Yield |
---|---|
With hydrogenchloride at 20℃; | 98% |
With hydrogenchloride at 20℃; | 98% |
With thionyl chloride at 0 - 20℃; for 48.5h; | 91% |
Conditions | Yield |
---|---|
With sodium hydroxide In ethyl acetate; tert-butyl alcohol | 98% |
With sodium hydroxide In tert-butyl alcohol at 20℃; |
1,3-bis(diphenylphosphino)propane digold(I) dichloride
ethanol
3,3-dimethyl-D-cysteine
water
Conditions | Yield |
---|---|
With sodium hydroxide at 20℃; for 2h; | 97% |
formaldehyd
3,3-dimethyl-D-cysteine
(S)-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid
Conditions | Yield |
---|---|
In ethanol; water at 20℃; for 18h; | 96% |
In water at 0 - 20℃; for 23h; | 81% |
With pyridine In ethanol; water at 110℃; for 0.0833333h; Microwave irradiation; | 76% |
3,3-dimethyl-D-cysteine
Conditions | Yield |
---|---|
In water stirring of BiOCl into a soln. of D-(-)-penicillamine in water at 40°C; stirring for 15 min at 40°C; filtration;; crystallization on storing at room temperature; washing with cold water; drying; elem. anal.;; | 96% |
Conditions | Yield |
---|---|
With [4,4’-bis(1,1-dimethylethyl)-2,2’-bipyridine-N1,N1‘]bis [3,5-difluoro-2-[5-(trifluoromethyl)-2-pyridinyl-N]phenyl-C]iridium(III) hexafluorophosphate; triethyl phosphite In aq. phosphate buffer; acetonitrile at 20℃; for 0.5h; pH=6.5; Irradiation; | 96% |
3,3-dimethyl-D-cysteine
Conditions | Yield |
---|---|
In dichloromethane byproducts: acetylacetone; N2-atmosphere; dropwise addn. of Au-complex soln. to 2 equiv. of ligand soln. (room temp.), stirring (1 h); filtration (Celite), concn., pptn. on Et2O addn., filtration, recrystn. (CH2Cl2/Et2O), drying (vac.); elem. anal.; | 95% |
Conditions | Yield |
---|---|
With KOH In potassium hydroxide aq. KOH; AgNO3 soln. (pH 5) added to alkaline soln. of penicillamine; solid filtered, washed (EtOH), dried (P4O10); elem. anal.; | 95% |
Conditions | Yield |
---|---|
With KOH; HCl In water aurate soln. (pH 5) added to alkaline soln. of penicillamine, pH 9, thenHCl added dropwise, final pH 4; solid filtered, washed (EtOH), dried (P4O10); elem. anal.; | 95% |
Conditions | Yield |
---|---|
Stage #1: 3,3-dimethyl-D-cysteine; tetrahydrothiophene gold(I)chloride; bis-diphenylphosphinomethane In ethanol; dichloromethane at 20℃; for 1h; Darkness; Stage #2: With sodium hydroxide In ethanol; dichloromethane Stage #3: water In methanol at 20℃; for 840h; | 95% |
Conditions | Yield |
---|---|
With potassium hydroxide In ethanol at 20℃; for 2h; | 95% |
Conditions | Yield |
---|---|
In methanol; water for 4h; Ambient temperature; | 93% |
Conditions | Yield |
---|---|
With hydrogenchloride; sodium hydrogencarbonate In water at 70℃; for 0.75h; | 91.8% |
3,3-dimethyl-D-cysteine
acetone
(4S)-2,2,5,5-tetramethylthiazolidine-4-carboxylic acid
Conditions | Yield |
---|---|
at 55℃; for 2h; | 91.2% |
for 2h; Condensation; Heating; | 90% |
In water | 88% |
In water for 15h; Ambient temperature; | 70% |
3,3-dimethyl-D-cysteine
opianic acid
(3S,10R)-2,3,5,10-Tetrahydro-6,7-dimethoxy-2,2-dimethyl-5-oxo-<1,3>-thiazolo<2,3-a>isoindol-3-carbonsaeure
Conditions | Yield |
---|---|
In water for 1h; Heating; | 91% |
Conditions | Yield |
---|---|
With N,N,N',N'-tetramethylguanidine In tetrahydrofuran at 50℃; for 1h; Inert atmosphere; | 91% |
3,3-dimethyl-D-cysteine
N-methyl2-piperidone diethyl acetal
(S)-3-Mercapto-3-methyl-2-[1-methyl-piperidin-(2E)-ylideneamino]-butyric acid
Conditions | Yield |
---|---|
In ethanol at 20 - 25℃; for 5h; | 90% |
Conditions | Yield |
---|---|
In phosphate buffer; water at 20℃; for 0.666667h; pH=7.4; | 90% |
In phosphate buffer at 37℃; pH=7.4; Product distribution; Kinetics; |
Conditions | Yield |
---|---|
In benzene | A 90% B n/a |
[(ClAu)]3(1,1,1-tris(diphenylphosphinomethyl)ethane)
3,3-dimethyl-D-cysteine
water
Conditions | Yield |
---|---|
In ethanol at 20℃; for 1h; | 90% |
Conditions | Yield |
---|---|
With sodium hydroxide; sodium carbonate In methanol; water; N,N-dimethyl-formamide | 89.6% |
The D,3-Mercaptovaline with CAS registry number of 52-67-5 is also called D-Valine, 3-mercapto-. The IUPAC name is (2S)-2-amino-3-methyl-3-sulfanylbutanoic acid. Its EINECS registry number is 200-148-8. In addition, the molecular formula is C5H11NO2S and the molecular weight is 149.21. It is a kind of white to off-white crystalline powder and belongs to the classes of Amino Acids; Biochemistry; non-Proteinorganic Amino Acids; Miscellaneous Compounds; Antibiotics. And it is stable and incompatible with strong oxidizing agents.
Physical properties about this chemical are: (1)ACD/LogP: 0.85; (2)# of Rule of 5 Violations: 0 ; (3)ACD/BCF (pH 5.5): 1; (4)ACD/BCF (pH 7.4): 1; (5)ACD/KOC (pH 5.5): 1; (6)ACD/KOC (pH 7.4): 1; (7)#H bond acceptors: 3; (8)#H bond donors: 3; (9)#Freely Rotating Bonds: 4; (10)Polar Surface Area: 102.12 Å2; (11)Index of Refraction: 1.528; (12)Molar Refractivity: 38.134 cm3; (13)Molar Volume: 123.845 cm3; (14)Polarizability: 15.117 ×10-24cm3; (15)Surface Tension: 48.155 dyne/cm; (16)Density: 1.205 g/cm3; (17)Flash Point: 106.068 °C; (18)Enthalpy of Vaporization: 53.854 kJ/mol; (19)Boiling Point: 251.772 °C at 760 mmHg; (20)Vapour Pressure: 0.006 mmHg at 25°C.
Preparation of D,3-Mercaptovaline: it can be prepared by penicillin through synthesis or degradation. It also can be prepared by penicillin G potassium by means of hydrolysis.
Uses of D,3-Mercaptovaline: it can be used as antidoteit of some heavy metals such as copper and mercury. And it can be used in the treatment of Wilson's disease and rheumatoid arthritis. It does not apply to the hematopoiesis function obstacle patients, kidney function decline patients and who allergic to penicillin. In addition, it can react with formic acid to get N-formyl-penicillamine. This reaction will need reagent acetic anhydride. The reaction time is 3 hours at ambient temperature. The yield is about 78%.
When you are using this chemical, please be cautious about it as the following:
This chemical is irritating to eyes, respiratory system and skin and harmful by inhalation, in contact with skin and if swallowed. The evidence of a carcinogenic effect is limited. During using it, do not breathe dust and wear suitable protective clothing. Moreover, avoid contact with skin and eyes. In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
You can still convert the following datas into molecular structure:
(1)SMILES: CC(C)([C@H](C(=O)O)N)S
(2)InChI: InChI=1/C5H11NO2S/c1-5(2,9)3(6)4(7)8/h3,9H,6H2,1-2H3,(H,7,8)/t3-/m0/s1
(3)InChIKey: VVNCNSJFMMFHPL-VKHMYHEABH
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
child | TDLo | oral | 40mg/kg/1W-I (40mg/kg) | BLOOD: LEUKOPENIA SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" | Archives of Internal Medicine. Vol. 145, Pg. 2271, 1985. |
human | TDLo | oral | 21mg/kg/D (21mg/kg) | KIDNEY, URETER, AND BLADDER: PROTEINURIS BLOOD: LEUKOPENIA BLOOD: THROMBOCYTOPENIA | JAMA, Journal of the American Medical Association. Vol. 240, Pg. 1870, 1978. |
human | TDLo | oral | 893mg/kg/30W- (893mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS LUNGS, THORAX, OR RESPIRATION: DYSPNEA MUSCULOSKELETAL: OTHER CHANGES | Journal of Rheumatology. Vol. 11, Pg. 251, 1984. |
man | TDLo | oral | 400mg/kg/4W-I (400mg/kg) | LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES BLOOD: HEMORRHAGE | Journal of Rheumatology. Vol. 13, Pg. 963, 1986. |
man | TDLo | oral | 482mg/kg/19W- (482mg/kg) | BLOOD: THROMBOCYTOPENIA SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" | Archives of Internal Medicine. Vol. 143, Pg. 1487, 1983. |
man | TDLo | unreported | 3200mg/kg/84W (3200mg/kg) | SENSE ORGANS AND SPECIAL SENSES: OTHER CHANGES: OLFACTION SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" | British Medical Journal. Vol. 296, Pg. 1332, 1988. |
mouse | LD50 | intraperitoneal | 298mg/kg (298mg/kg) | Yakugaku Zasshi. Journal of Pharmacy. Vol. 94, Pg. 1419, 1974. | |
mouse | LD50 | intravenous | 3840mg/kg (3840mg/kg) | LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Arzneimittel-Forschung. Drug Research. Vol. 25, Pg. 162, 1975. |
mouse | LD50 | oral | 720mg/kg (720mg/kg) | Pharmaceutical Chemistry Journal Vol. 21, Pg. 842, 1987. | |
mouse | LD50 | subcutaneous | 3810mg/kg (3810mg/kg) | Drugs in Japan Vol. 6, Pg. 758, 1982. | |
rat | LD50 | intraperitoneal | 2080mg/kg (2080mg/kg) | Drugs in Japan Vol. 6, Pg. 758, 1982. | |
rat | LD50 | intravenous | 2gm/kg (2000mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 22, Pg. 1434, 1972. | |
rat | LD50 | oral | 6170mg/kg (6170mg/kg) | Drugs in Japan Vol. 6, Pg. 758, 1982. | |
rat | LD50 | subcutaneous | 4020mg/kg (4020mg/kg) | Drugs in Japan Vol. 6, Pg. 758, 1982. | |
women | LDLo | oral | 150mg/kg/30D- (150mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS CARDIAC: ARRHYTHMIAS (INCLUDING CHANGES IN CONDUCTION) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" | Annals of Internal Medicine. Vol. 98, Pg. 327, 1983. |
women | TDLo | oral | 105mg/kg/6W-I (105mg/kg) | SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" | British Medical Journal. Vol. 294, Pg. 1101, 1987. |
women | TDLo | oral | 112mg/kg/1W-I (112mg/kg) | BLOOD: AGRANULOCYTOSIS SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" | Archives of Internal Medicine. Vol. 145, Pg. 2271, 1985. |
women | TDLo | oral | 900mg/kg/26W- (900mg/kg) | SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" | Journal of Rheumatology. Vol. 12, Pg. 583, 1985. |
women | TDLo | oral | 650gm/kg/81W- (650000mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS MUSCULOSKELETAL: OTHER CHANGES | Arthritis and Rheumatism. Vol. 29, Pg. 560, 1986. |
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View